Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women

Novo Nordisk

Status and phase: Terminated; Phase 3

Conditions: Urinary Infections; Menopause

Treatments: Drug: estradiol, 25 mcg

Study type: Interventional

Funder types: Industry

Identifiers

NCT00560924

VAG-1458

Details and patient eligibility

About

This trial is conducted in Europe. The aim of this trial is to investigate the preventive effect of treatment with estradiol vaginal tablets on recurrent urinary tract infections (RUTI) in post-menopausal women with signs of urogenital ageing (UGA).

Enrollment: 6 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Post-menopausal woman with Urogenital ageing (UGA)
• Recurrent urinary tract infections defined as three or more urinary tract infections within the past twelve months

Exclusion criteria

• Known or suspected allergy to trial product or related products
• Present UTI
• History of RUTI during fertile period of life

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind